Skip to content
Exits and Outcomes
Digital health research, news, and analysis from Brian Dolan.
consider an Enterprise subscription
Prescription Digital Therapeutics
2 of 18
Breaking: Pear Therapeutics files for Chapter 11 bankruptcy
E&O readers analyze fate of Pear, PDTs. FDA-AI
FDA waiver ends Nov 7. Withings ScanWatch recall, revs
Pear seeks buyer. Lobbying for a CMS benefit category.
CMS to pay for VR-based CBT. No HCPCS for CanvasDx.
Cigna snubs RTM. Orexo PDT reorg. Pear CCO leaves.
Oui Therapeutics spun out a virtual clinic. physIQ revs, bankruptcy.
Three new Medicaid Rx digital therapeutic bills. Trials
Highmark won’t pay for every FDA-cleared prescription digital therapeutic. Clinical Trials.
Florida Medicaid covers Pear. MedRhythms pivotal. Trials
1 of 18